News
The First Oral GLP-1 Weight Loss Pill With No Food or Injection Requirements Is Now Available
Eli Lilly's Foundayo (orforglipron) is the first oral GLP-1 obesity pill with no food or water restrictions. FDA approved it April 1, 2026. Here is what patients should know.
→
Scientists Find a Way to Make a Failing Last-Resort Antibiotic Work Again Against Drug-Resistant Bacteria
Scientists paired vancomycin with a new compound called pghi-4, restoring the antibiotic's ability to kill drug-resistant VRE bacteria in lab and mouse studies published in 2026.
→
The U.S. May Lose Its Measles-Free Status in November. Here Is What That Means and How It Happened
PAHO will evaluate U.S. measles elimination status in November 2026. With 2,295 cases and 34 outbreaks, experts say the evidence of endemic spread is already clear.
→
